julie gralow, md, on the implications of the persephone trial in early her2 breast cancer
Published 6 years ago • 50 plays • Length 0:32
Download video MP4
Download video MP3
Similar videos
-
2:27
julie gralow, md, reflects on the persephone trial from the 2018 asco annual meeting
-
2:33
dr. gralow gives an analysis of the apt trial
-
1:05
julie gralow, md, speaks to the significance of the monaleesa-3 study
-
1:56
persephone: 6 vs. 12-month adjuvant trastuzumab in early breast cancer
-
0:52
julie gralow, md, tells us about the sandpiper proof of concept trial presented at acso 2018
-
1:46
dr. murthy on caveats of the persephone trial in breast cancer
-
16:42
our lady of perpetural succor (27 june): history of the devotion
-
1:04:45
episode 8: healthspan horizons w/ dr. aubrey de grey 🦾
-
31:21
novel therapeutics for breast cancer: her2 and triple negative disease; new pathways, targets
-
16:11
dr. julie r. gralow discusses findings from the rxponder study released at sabcs 2020
-
0:44
julie gralow, md, regarding the reduction in cardiac events in the persephone study
-
1:30
neelima denduluri, md, offers opinion on the persephone trial in early her2 breast cancer
-
5:07
julie gralow, md, summarizes the rxponder trial from the 2020 san antonio breast cancer symposium
-
2:01
julie gralow, md, on the kristine study
-
0:52
dr. julie gralow discusses the antibody drug conjugate t-dm1 for breast cancer
-
0:37
julie gralow, md, comments on the practice-changing implications of the tailorx study
-
1:14
julie gralow, md, shares her thoughts on new drugs in development for breast cancer.
-
1:57
dr. gralow on adjuvant bisphosphonates for breast cancer
-
2:11
dr. julie gralow on treating breast cancer bone metastases
-
1:27
dr. julie gralow on the importance of genetic testing for breast cancer
-
2:35
julie gralow, md, elaborates on the issue of resistance to endocrine therapies
-
2:40
dr. julie gralow discusses the swog s0500 trial
Clip.africa.com - Privacy-policy